A vast number of people are affected by different types of peripheral neuropathies in United States alone. Peripheral nerve injuries frequently occur in people involved in accidents or in combat veterans who suffered loss ...
Oct 27, 2016
0
3
Consuming too much folate (vitamin B9) is associated with increased risk for a nerve-damage disorder in older adults who have a common genetic variant. Although variable by race or ethnic background, an estimated one in six ...
Oct 12, 2016
0
1
(HealthDay)—Pregabalin significantly improves neuropathic pain, irrespective of the time since pain onset, according to a study published online Sept. 2 in Pain Practice.
Sep 9, 2016
0
9
Whole exome sequencing has revealed a novel mechanism and potential target for treating peripheral neuropathy, a condition that afflicts millions of people in the United States alone.
Aug 3, 2016
0
10
Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, but its use can be limited by significant side effects. Researchers from Moffitt Cancer Center report prostate cancer patients ...
May 13, 2016
0
1
A new mathematical model to predict the pressure on feet, which could then lead to the prevention of foot ulcers, could be developed thanks to academics at Plymouth University.
May 3, 2016
0
31
Recent research by Sandra Rieger, Ph.D., of the MDI Biological Laboratory identifying the underlying mechanisms of peripheral neuropathy, or nerve damage, has raised the prospect that drug therapies can be developed for the ...
Apr 14, 2016
0
232
A research team from Wayne State University recently published a paper in the Journal of Clinical Investigation that provides a paradigm shift in the understanding of cellular and molecular mechanisms underlying diabetic ...
Apr 11, 2016
0
4
The Mount Desert Island (MDI) Biological Laboratory has announced that assistant professor Sandra Rieger, Ph.D., has identified two drugs that could potentially be used to reverse peripheral nerve damage, or peripheral neuropathy, ...
Feb 22, 2016
0
19
(HealthDay)—Halaven (eribulin mesylate) has been approved by the U.S. Food and Drug Administration as the first chemotherapy drug shown to improve survival in people with advanced liposarcoma.
Jan 29, 2016
0
1
